Erratum to 'Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome': [ESMO Open Volume 6, Issue 1, February 2021, 100005]
ESMO Open. 2021 Apr;6(2):100056.
doi: 10.1016/j.esmoop.2021.100056.
Epub 2021 Jan 28.
1 The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UK; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK. Electronic address: [email protected].
2 The University of Manchester, Manchester, UK; Digital Experimental Cancer Medicine Team, Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park, UK.
3 The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; The University of Liverpool, Liverpool, UK.
4 The Christie NHS Foundation Trust, Manchester, UK.
5 The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UK.
6 University Hospitals of Morecambe Bay, Kendal, UK.
7 Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.
8 University of Dundee, Dundee, UK.
9 The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.
10 Cancer Sciences Academic Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
11 Leicester Cancer Research Centre, University of Leicester, Leicester, UK.
12 University Hospitals Plymouth NHS Trust, Plymouth, UK.
15 Bristol Haematology and Oncology Centre, Bristol, UK.
16 Leicester Cancer Research Centre, University of Leicester, Leicester, UK; Oncology Department, University Hospitals of Leicester NHS Trust, Leicester, UK.
17 Bristol Haematology and Oncology Centre, Bristol, UK; Sunrise Oncology Centre, Royal Cornwall Hospital, Truro, UK.
18 National Institute for Biological Standards and Control, Potters Bar, UK.
19 Institute of Infection and Global Health, University of Liverpool and Tropical and Infectious Diseases Unit, Royal Liverpool Hospital, Liverpool, UK.
20 Cancer Research UK Manchester Institute, Cancer Biomarker Centre, The University of Manchester, Alderley Park, UK.